NCT00613197View on ClinicalTrials.gov

EPANOVA in Crohn's Disease, Study 1

PHASE3CompletedINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Crohn's Disease
Interventions
DRUG

Epanova

4g/day in divided doses

Trial Locations (1)

3000

University of Leuven, Leuven

All Listed Sponsors
lead

Tillotts Pharma AG

INDUSTRY

NCT00613197 - EPANOVA in Crohn's Disease, Study 1 | Biotech Hunter | Biotech Hunter